Clinical studies of safety and effectiveness of orphan products; availability of grants; request for applications.  Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Notice.
The Food and Drug Administration (FDA) is announcing changes to its Orphan Products Development (OPD) grant program for fiscal year (FY) 2000.  The previous announcement of this program, which was published in the Federal Register of August 5, 1998 (63 FR 41855), is superseded by this announcement.  In the future, a new announcement will be published annually.
D002986:Clinical Trials as Topic / Q000191:economics; D004341:Drug Evaluation / Q000191:economics* / Q000331:legislation & jurisprudence; D006292:Health Priorities; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence* / Q000592:standards; D012109:Research Support as Topic / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration